Overview
CPRX market data
Price History
CPRX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CPRX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Angelini Pharma Completes Acquisition of Catalyst PharmaceuticalsGlobenewswire Inc · Jul 16, 2026, 11:00 AM
8-K filing — CATALYST PHARMACEUTICALS, INC. (CPRX)SEC EDGAR · Jul 15, 2026, 9:36 PM
Solaris Energy Infrastructure To Replace Catalyst Pharmaceuticals In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On July 15, 2026Benzinga · Jul 9, 2026, 9:25 PM
Catalyst Pharmaceuticals Announces Topline Results From Two-Part Phase 1 Clinical Study Of Vamorolone In Healthy Adult VolunteersBenzinga · Jun 30, 2026, 12:15 PM
HC Wainwright & Co. Downgrades Catalyst Pharmaceuticals to Neutral, Lowers Price Target to $31.5Benzinga · May 28, 2026, 4:43 PM
Earnings Scheduled For May 11, 2026Benzinga · May 11, 2026, 11:11 AM
Family-Run Angelini Pharma Buys Catalyst Pharmaceuticals For Over 4 BillionBenzinga · May 7, 2026, 4:05 PM